Cargando…
Late‐life onset psychotic symptoms and incident cognitive impairment in people without dementia: Modification by genetic risk for Alzheimer's disease
INTRODUCTION: Late‐life onset psychosis is associated with faster progression to dementia in cognitively normal people, but little is known about its relationship with cognitive impairment in advance of dementia. METHODS: Clinical and genetic data from 2750 people ≥50 years of age without dementia w...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150165/ https://www.ncbi.nlm.nih.gov/pubmed/37139261 http://dx.doi.org/10.1002/trc2.12386 |
_version_ | 1785035311595651072 |
---|---|
author | Creese, Byron Arathimos, Ryan Aarsland, Dag Ballard, Clive Brooker, Helen Hampshire, Adam Corbett, Anne Ismail, Zahinoor |
author_facet | Creese, Byron Arathimos, Ryan Aarsland, Dag Ballard, Clive Brooker, Helen Hampshire, Adam Corbett, Anne Ismail, Zahinoor |
author_sort | Creese, Byron |
collection | PubMed |
description | INTRODUCTION: Late‐life onset psychosis is associated with faster progression to dementia in cognitively normal people, but little is known about its relationship with cognitive impairment in advance of dementia. METHODS: Clinical and genetic data from 2750 people ≥50 years of age without dementia were analyzed. Incident cognitive impairment was operationalized using the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) and psychosis was rated using the Mild Behavioral Impairment Checklist (henceforth MBI‐psychosis). The whole sample was analyzed before stratification on apolipoprotein E (APOE) ε4 status. RESULTS: In Cox proportional hazards models, MBI‐psychosis had a higher hazard for cognitive impairment relative to the No Psychosis group (hazard ratio [HR]: 3.6, 95% confidence interval [CI]: 2.2–6, p < 0.0001). The hazard for MBI‐psychosis was higher in APOE ε4 carriers and there was an interaction between the two (HR for interaction: 3.4, 95% CI: 1.2–9.8, p = 0.02). DISCUSSION: Psychosis assessment in the MBI framework is associated with incident cognitive impairment in advance of dementia. These symptoms may be particularly important in the context of APOE genotype. |
format | Online Article Text |
id | pubmed-10150165 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-101501652023-05-02 Late‐life onset psychotic symptoms and incident cognitive impairment in people without dementia: Modification by genetic risk for Alzheimer's disease Creese, Byron Arathimos, Ryan Aarsland, Dag Ballard, Clive Brooker, Helen Hampshire, Adam Corbett, Anne Ismail, Zahinoor Alzheimers Dement (N Y) Research Articles INTRODUCTION: Late‐life onset psychosis is associated with faster progression to dementia in cognitively normal people, but little is known about its relationship with cognitive impairment in advance of dementia. METHODS: Clinical and genetic data from 2750 people ≥50 years of age without dementia were analyzed. Incident cognitive impairment was operationalized using the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) and psychosis was rated using the Mild Behavioral Impairment Checklist (henceforth MBI‐psychosis). The whole sample was analyzed before stratification on apolipoprotein E (APOE) ε4 status. RESULTS: In Cox proportional hazards models, MBI‐psychosis had a higher hazard for cognitive impairment relative to the No Psychosis group (hazard ratio [HR]: 3.6, 95% confidence interval [CI]: 2.2–6, p < 0.0001). The hazard for MBI‐psychosis was higher in APOE ε4 carriers and there was an interaction between the two (HR for interaction: 3.4, 95% CI: 1.2–9.8, p = 0.02). DISCUSSION: Psychosis assessment in the MBI framework is associated with incident cognitive impairment in advance of dementia. These symptoms may be particularly important in the context of APOE genotype. John Wiley and Sons Inc. 2023-04-30 /pmc/articles/PMC10150165/ /pubmed/37139261 http://dx.doi.org/10.1002/trc2.12386 Text en © 2023 The Authors. Alzheimer's & Dementia: Translational Research & Clinical Interventions published by Wiley Periodicals LLC on behalf of Alzheimer's Association. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Creese, Byron Arathimos, Ryan Aarsland, Dag Ballard, Clive Brooker, Helen Hampshire, Adam Corbett, Anne Ismail, Zahinoor Late‐life onset psychotic symptoms and incident cognitive impairment in people without dementia: Modification by genetic risk for Alzheimer's disease |
title | Late‐life onset psychotic symptoms and incident cognitive impairment in people without dementia: Modification by genetic risk for Alzheimer's disease |
title_full | Late‐life onset psychotic symptoms and incident cognitive impairment in people without dementia: Modification by genetic risk for Alzheimer's disease |
title_fullStr | Late‐life onset psychotic symptoms and incident cognitive impairment in people without dementia: Modification by genetic risk for Alzheimer's disease |
title_full_unstemmed | Late‐life onset psychotic symptoms and incident cognitive impairment in people without dementia: Modification by genetic risk for Alzheimer's disease |
title_short | Late‐life onset psychotic symptoms and incident cognitive impairment in people without dementia: Modification by genetic risk for Alzheimer's disease |
title_sort | late‐life onset psychotic symptoms and incident cognitive impairment in people without dementia: modification by genetic risk for alzheimer's disease |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150165/ https://www.ncbi.nlm.nih.gov/pubmed/37139261 http://dx.doi.org/10.1002/trc2.12386 |
work_keys_str_mv | AT creesebyron latelifeonsetpsychoticsymptomsandincidentcognitiveimpairmentinpeoplewithoutdementiamodificationbygeneticriskforalzheimersdisease AT arathimosryan latelifeonsetpsychoticsymptomsandincidentcognitiveimpairmentinpeoplewithoutdementiamodificationbygeneticriskforalzheimersdisease AT aarslanddag latelifeonsetpsychoticsymptomsandincidentcognitiveimpairmentinpeoplewithoutdementiamodificationbygeneticriskforalzheimersdisease AT ballardclive latelifeonsetpsychoticsymptomsandincidentcognitiveimpairmentinpeoplewithoutdementiamodificationbygeneticriskforalzheimersdisease AT brookerhelen latelifeonsetpsychoticsymptomsandincidentcognitiveimpairmentinpeoplewithoutdementiamodificationbygeneticriskforalzheimersdisease AT hampshireadam latelifeonsetpsychoticsymptomsandincidentcognitiveimpairmentinpeoplewithoutdementiamodificationbygeneticriskforalzheimersdisease AT corbettanne latelifeonsetpsychoticsymptomsandincidentcognitiveimpairmentinpeoplewithoutdementiamodificationbygeneticriskforalzheimersdisease AT ismailzahinoor latelifeonsetpsychoticsymptomsandincidentcognitiveimpairmentinpeoplewithoutdementiamodificationbygeneticriskforalzheimersdisease |